CClinicalTrials.gg
Status unknownNCT04396782Updated Jun 11, 2020

Effectiveness of Immersive Virtual Reality in Functional Rehabilitation in Older People With Knee Arthroplasty

An interventional study of Physioterapy rehabilitation with IVR and standard physiotherapy rehabilitation in Arthroplasty, Replacement, Knee, sponsored by University of Malaga. Status unknown at 1 site in Spain. Open to participants aged 60 Years to 75 Years. Per ClinicalTrials.gov, last updated 2020-06-11.

Sponsored by University of Malaga · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jun 2020), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
60 Years to 75 Years
Sex
All
01

Study summary

The number of knee arthroplasties performed each year is constantly increasing. Although the outcome is generally favourable, 10-20% do not achieve a satisfactory clinical result. This study evaluates the effectiveness of immersive virtual reality rehabilitation in older people who have undergone knee arthroplasty surgery. The 6 Meter Walking Test is used to determine the improvement of patients after the procedure.

02

Conditions studied

  • Arthroplasty, Replacement, Knee
03

In context

Lead sponsor

University of Malaga is the lead sponsor of 118 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • people who are admitted to one of the two chosen residences on the Costa del Sol who have had, or will have, a total knee arthroplasty recently.
  • People between 60-75, who want to receive rehabilitation treatment.

Exclusion criteria

Exclusion Criteria:

  • Patients who refuse to participate or who suffer serious post-operative complications.
  • patients with neurological or cognitive impairment that could interfere with the performance of the rehabilitative treatment will be excluded.
  • Those with any severe cardiovascular or pulmonary disease that would prevent them from exercising and also those who are not allowed physical activity for any reason.
  • Those with poor visual acuity who are unable to see the visual characteristics of the screen.
  • Patients with severe contralateral knee osteoarthritis (>5/10 pain when climbing stairs) or other orthopaedic conditions that limited function and required an alternative simultaneous operation, e.g. severe lumbar spinal stenosis, severe OA of the hip or ankle...
  • Those who are scheduled for other lower limb surgery in the next 6 months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
140 participants (estimated)

Study arms

  • Experimental
    physiotherapy rehabilitation with IVR

    This program includes: static bicycle with virtual reality glasses, analytical lower limb exercises, global lower limb exerciseswith virtual reality glasses and activities to be done at home.

    Other: standard physiotherapy rehabilitation

  • Active comparator
    standard physiotherapy rehabilitation

    static bicycle, analytical lower limb exercises, global lower limb exercises and activities to be done at home.

    Other: Physioterapy rehabilitation with IVR

Interventions

  • OtherPhysioterapy rehabilitation with IVR

    This program includes: static bicycle with virtual reality glasses, analytical lower limb exercises, global lower limb exerciseswith virtual reality glasses and activities to be done at home.

  • Otherstandard physiotherapy rehabilitation

    static bicycle, analytical lower limb exercises, global lower limb exercises and activities to be done at home. This group will perform only five minutes of virtual reality play, but will not use their lower limbs. This way, the results of rehabilitation will not be affected and therapists and patients will be blinded.

06

What researchers measure

Primary outcomes

  1. Changes in six meter walking test (6-MWT) score

    Six-meter walking test is a a well-established outcome measure in a variety of diseases. It is accurate, reproducible, simple to administer, and well tolerated. The 6MWT is a robust assessment tool for use in clinical trials given its ability to quantitatively evaluate ambulation in a controlled environment. Participants will be asked to do quick laps in a flat corridor for 6 minutes with the verbal stimulus provided by the assessor at the end of each lap. A significant improvement threshold after surgery could be between 26 and 55m

    Time frame: Baseline, up to three an six months.

Secondary outcomes

  1. Sit to Stand Test

    Sit to Stand Test is a simple test to evaluate lower limb muscle strength and balance ability. This test measures the time it takes to sit down completely and get up 5 times with arms crossed over the chest and using a standard height chair (46cm).

    Time frame: Baseline, up to three an six months.

  2. The range of motion

    The range of motion (ROM) of knee flexion and extension measured with a goniometer.

    Time frame: Baseline, up to three an six months.

  3. The Oxford Knee Score (OKS)

    The Oxford Knee Score (OKS) is a specific measurement for assessing knee function and condition. It consists of 12 patient-reported questions that measure pain and function after knee arthroplasty surgery. Each question is scored from 0 to 4 with 4 being the best result, producing overall scores that range from 0 to 48, 48 being the best result.

    Time frame: Baseline, up to three an six months.

  4. The BERG scale

    The BERG scale which is a valid and sensitive scale for assessing balance in the elderly. It is based on the performance of 14 common balance tasks, experienced in daily life, which are graded on an ordinal scale of 5 points (0-4) with a maximum score of 56. Higher scores indicate better balance.

    Time frame: Baseline, up to three an six months.

  5. The McMaster Western Ontario McMaster Universities Osteoarthritis Index (WOMAC)

    The McMaster Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) is a specific questionnaire to assess the treatment effects of osteoarthritis on patients and their health-related quality of life. It is composed of a multidimensional scale with 24 items grouped in three dimensions: pain (5 items), stiffness (2 items) and physical function (17 items). They are answered by a Likert-type scale with 5 levels of response representing different degrees of intensity (none, mild, moderate, severe, extreme) scoring from 0 to 4. The final score is the sum of the scores of each item. The higher the score, the worse the patient's condition. The data are standardized on a range of 0 (best health condition) to 100 (worst possible condition).

    Time frame: Baseline, up to three an six months.

  6. The User Satisfaction Evaluation Questionnaire

    The User Satisfaction Evaluation Questionnaire (USEQ) is a questionnaire to evaluate the satisfaction and ease of use of virtual rehabilitation systems. It includes, with a 5-point Likert scale, 6 questions which we can see in Annex 4. The total score ranges from 6 (low satisfaction) to 30 (excellent satisfaction).

    Time frame: up to six months

07

Study locations

1 site
  • University of Málaga
    Málaga, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 11, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04396782
Lead sponsor
University of Malaga
Collaborators
Carmen Ruiz Vergara, Rocío Martín Valero
Responsible party
Rocío Martín Valero (PhD, University of Malaga) — Principal investigator
First posted
May 21, 2020
Start date
Jan 15, 2021 (estimated)
Primary completion
Jul 15, 2021 (estimated)
Completion
Sep 30, 2021 (estimated)
Last update
Jun 11, 2020

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion